{
    "Trade/Device Name(s)": [
        "ETI-MAX 3000TM",
        "DiaSorin ETI-MAX 3000TM"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K052794",
    "Predicate Device Reference 510(k) Number(s)": [
        "K922081",
        "K973177"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJF"
    ],
    "Summary Letter Date": "March 31, 2006",
    "Summary Letter Received Date": "October 7, 2005",
    "Submission Date": "September 29, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.2170"
    ],
    "Regulation Name(s)": [
        "Micro Chemistry Analyzer for Clinical Use"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "Antinuclear antibodies (ANA)",
        "ENA (Extractable Nuclear Antigen) panel",
        "Anti-SS-A (Ro) antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ETI-MAX 3000TM"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Photometric measurement"
    ],
    "Methodologies": [
        "Microtiter plate EIA",
        "Photometric evaluation"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Automated system",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin ETI-MAX 3000TM automated microtiter plate analyzer for qualitative and semi-quantitative immunology/autoimmune EIA assays",
    "Indications for Use Summary": "Fully automated EIA microtiter plate analyzer for complete sample processing and photometric evaluation of qualitative and semi-quantitative immunology and autoimmune assays, including ANAScreen, Anti-SS-A(Ro), and ENA panels",
    "fda_folder": "Clinical Chemistry"
}